
$4.3BIndia’s exports in 2025
161countries bought from India in 2025
2.7×change since 2013 ($1.6B)
21%of chapter 29 exports
India’s exports, year by year
US$, calendar years, all destinations combined. Source: UN Comtrade (India’s own reports).
Biggest buyers, 2025
- USA
- Switzerland
- Netherlands
- Brazil
- China
- Belgium
- Spain
- United Kingdom
- Japan
- Germany
Ranked by value. Country-by-country figures are not shown.
What's inside 2933
22 codes India exports2933.99Heterocycliccompoundswithnitrogen hetero-atom(s) only - compounds containing an unfused pyrazole ring…$1.2B in 2025 — 29% of the total2933.39Heterocycliccompoundswithnitrogen hetero-atom(s) only — other types$1.0B in 2025 — 24% of the total2933.59Heterocycliccompoundswithnitrogen hetero-atom(s) only — other types$689M in 2025 — 16% of the total2933.19Heterocycliccompoundswithnitrogen hetero-atom(s) only — other types$368M in 2025 — 9% of the total2933.29Heterocycliccompoundswithnitrogen hetero-atom(s) only — other types$293M in 2025 — 7% of the total2933.79Lactams: other lactams$186M in 2025 — 4% of the total2933.49Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated)…$168M in 2025 — 4% of the total2933.69Heterocycliccompoundswithnitrogen hetero-atom(s) only — other types$106M in 2025 — 2% of the total2933.31Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Pyridine and…$90M in 2025 — 2% of the total2933.32Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Piperidine and…$29M in 2025 — under 1% of the total2933.33Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Alfentanil…$23M in 2025 — under 1% of the total2933.61Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: Melamine$22M in 2025 — under 1% of the total2933.91Heterocycliccompoundswithnitrogen hetero-atom(s) only — other: Alprazolam (INN), camazepam (INN) chloridiazepoxide (INN), kg. 10% -clonazepam (INN), clorazepate…$19M in 2025 — under 1% of the total2933.11Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure): Phenazone…$10M in 2025 — under 1% of the total2933.21Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: Hydantoin and…$4.8M in 2025 — under 1% of the total2933.41Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated)…$3.7M in 2025 — under 1% of the total2933.53Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure:…$2.4M in 2025 — under 1% of the total2933.72Lactams: Clobazam (INN) and methyprylon (INN)$2.3M in 2025 — under 1% of the total2933.54Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure:…$1.6M in 2025 — under 1% of the total2933.52Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure:…$990K in 2025 — under 1% of the total2933.71Lactams: 6-Hexanelactam (epsilon-caprolactam)$500K in 2025 — under 1% of the total2933.92Azinphos-methyl (ISO)$200K in 2025 — under 1% of the total
Other codes in chapter 29
2902Cyclic hydrocarbons$1.4B in 20252942Other organic compounds$1.3B in 20252921Amine- function compounds$1.1B in 20252941Antibiotics$935M in 20252934Nucleic acids and their salts$840M in 20252924Carboxyamide-functioncompounds$831M in 20252915Saturatedacyclicmonocarboxylicacidsandtheir anhydrides, halides, peroxides andperoxyacids$710M in 20252922Oxygen-functionamino-compounds - amino-alcohols, other than those containing more than…$705M in 20252918Carboxylicacidswithadditionaloxygen function and their anhydrides, halides, peroxides and…$692M in 20252909Ethers, ether-alcohols, ether-phenols, ether-alcohol-phenols, alcoholperoxides, ether…$643M in 20252914Ketones and quinones$605M in 20252905Acyclic alcoholsand their halogenated, sulphonated, nitrated or nitrosated derivatives$507M in 2025